Ovid Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Ovid Therapeutics has a total shareholder equity of $87.8M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $144.0M and $56.2M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$105.83m |
Equity | US$87.80m |
Total liabilities | US$56.23m |
Total assets | US$144.03m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 1OT's short term assets ($109.6M) exceed its short term liabilities ($11.5M).
Long Term Liabilities: 1OT's short term assets ($109.6M) exceed its long term liabilities ($44.8M).
Debt to Equity History and Analysis
Debt Level: 1OT is debt free.
Reducing Debt: 1OT has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 1OT has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 1OT has sufficient cash runway for 1.2 years if free cash flow continues to grow at historical rates of 5.6% each year.